Not using Bio­strength for BE [Regulatives / Guidelines]

posted by zheng791 – US, 2018-07-13 19:31 (875 d 03:15 ago) – Posting: # 19052
Views: 2,230

Our firm is developing a multi-strength product which is a high potency, NTI oral dosage. The highest strength is 0.3 mg. The product guidance requests to use 0.3 mg x2 tablets for dosing and biowaive the lower strengths. However, our firm does not want to develop 0.3 mg. They have 0.15 mg as highest strength. Can I use 0.15 mg x4 for dosing and biowaive lower strengths? These strengths are similarly proportional, that is have the same tablet weight, the filler weight changes to compensate the API change.

Thank you

Complete thread:

 Admin contact
21,240 posts in 4,431 threads, 1,482 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Friday 22:46 UTC (Europe/Vienna)

Normality is a myth; there never was, and never will be,
a normal distribution.    Roy C. Geary

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz